These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1453 related items for PubMed ID: 32605588

  • 1. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
    Terkelsen T, Russo F, Gromov P, Haakensen VD, Brunak S, Gromova I, Krogh A, Papaleo E.
    Breast Cancer Res; 2020 Jun 30; 22(1):73. PubMed ID: 32605588
    [Abstract] [Full Text] [Related]

  • 2. Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis.
    Qattan A, Al-Tweigeri T, Alkhayal W, Suleman K, Tulbah A, Amer S.
    Genes (Basel); 2021 Apr 09; 12(4):. PubMed ID: 33918859
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer.
    Cascione L, Gasparini P, Lovat F, Carasi S, Pulvirenti A, Ferro A, Alder H, He G, Vecchione A, Croce CM, Shapiro CL, Huebner K.
    PLoS One; 2013 Apr 09; 8(2):e55910. PubMed ID: 23405235
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer.
    Bottai G, Diao L, Baggerly KA, Paladini L, Győrffy B, Raschioni C, Pusztai L, Calin GA, Santarpia L.
    Int J Mol Sci; 2017 Jan 19; 18(1):. PubMed ID: 28106823
    [Abstract] [Full Text] [Related]

  • 7. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R, Xing L, Wang M, Chi H, Zhang L, Chen J.
    Cell Physiol Biochem; 2018 Jan 19; 50(2):473-488. PubMed ID: 30308479
    [Abstract] [Full Text] [Related]

  • 8. Computational Identification of Sex-Biased Biomarker MicroRNAs and Genes Associated with Immune Infiltration in Breast Cancer.
    Li EW, Bai Y.
    Genes (Basel); 2021 Apr 14; 12(4):. PubMed ID: 33919884
    [Abstract] [Full Text] [Related]

  • 9. Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8.
    Roychowdhury A, Jondhale M, Saldanha E, Ghosh D, Kumar Panda C, Chandrani P, Mukherjee N.
    Gene; 2021 Aug 05; 792():145728. PubMed ID: 34022297
    [Abstract] [Full Text] [Related]

  • 10. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
    Thakur S, Grover RK, Gupta S, Yadav AK, Das BC.
    PLoS One; 2016 Aug 05; 11(7):e0158946. PubMed ID: 27404381
    [Abstract] [Full Text] [Related]

  • 11. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY, Kuo WH, Hung JH, Lee CY, Lee YH, Chang YC, Lin WC, Shen CY, Huang CS, Hsieh FJ, Lai LC, Tsai MH, Chang KJ, Chuang EY.
    Mol Cancer; 2015 Feb 10; 14():36. PubMed ID: 25888956
    [Abstract] [Full Text] [Related]

  • 12. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
    Li Z, Peng Z, Gu S, Zheng J, Feng D, Qin Q, He J.
    Anticancer Res; 2017 Aug 10; 37(8):4455-4468. PubMed ID: 28739740
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential distribution of microRNAs in breast cancer grouped by clinicopathological subtypes.
    Li JY, Jia S, Zhang WH, Zhang Y, Kang Y, Li PS.
    Asian Pac J Cancer Prev; 2013 Aug 10; 14(5):3197-203. PubMed ID: 23803104
    [Abstract] [Full Text] [Related]

  • 15. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
    Qiu P, Guo Q, Yao Q, Chen J, Lin J.
    PLoS One; 2021 Aug 10; 16(11):e0254283. PubMed ID: 34797837
    [Abstract] [Full Text] [Related]

  • 16. Integrated analysis of the potential roles of miRNA‑mRNA networks in triple negative breast cancer.
    Zhu H, Dai M, Chen X, Chen X, Qin S, Dai S.
    Mol Med Rep; 2017 Aug 10; 16(2):1139-1146. PubMed ID: 28627677
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
    Fkih M'hamed I, Privat M, Ponelle F, Penault-Llorca F, Kenani A, Bignon YJ.
    Cell Oncol (Dordr); 2015 Dec 10; 38(6):433-42. PubMed ID: 26392359
    [Abstract] [Full Text] [Related]

  • 20. Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response.
    Xing AY, Wang B, Li YH, Chen X, Wang YW, Liu HT, Gao P.
    Pathol Oncol Res; 2021 Dec 10; 27():1609753. PubMed ID: 34257614
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 73.